Cite
HARVARD Citation
Persa, O. et al. (2021). Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients. Journal of immunotherapy. 44 (6), pp. 239-241. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Persa, O. et al. (2021). Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients. Journal of immunotherapy. 44 (6), pp. 239-241. [Online].